近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
O'Neill, E., Kolanowski, J., Yin, G., Broadhouse, K., Grieve, S., Renfrew, A., Bonnitcha, P., New, E. (2016). Reversible magnetogenic cobalt complexes. RSC Advances, 6(36), 30021-30027. [More Information]
Karaoun, N., Renfrew, A. (2015). A luminescent ruthenium(II) complex for light-triggered drug release and live cell imaging. Chemical Communications, 51(74), 14038-14041. [More Information]
Renfrew, A., Bryce, N., Hambley, T. (2015). Cobalt(III) chaperone complexes of curcumin: Photoreduction, cellular accumulation and light-selective toxicity towards tumour cells. Chemistry - A European Journal, 21(43), 15224-15234. [More Information]
Renfrew, A. (2014). Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery. Metallomics, 6(8), 1324-1335. [More Information]
Renfrew, A., Bryce, N., Hambley, T. (2013). Delivery and release of curcumin by a hypoxia-activated cobalt chaperone: a XANES and FLIM study. Chemical Science, 4(9), 3731-3739. [More Information]
Yamamoto, N., Renfrew, A., Kim, B., Bryce, N., Hambley, T. (2012). Dual Targeting of Hypoxic and Acidic Tumor Environments with a Cobalt(III) Chaperone Complex. Journal of Medicinal Chemistry, 55(24), 11013-11021. [More Information]
Renfrew, A., Juillerat-Jeanneret, L., Dyson, P. (2011). Adding diversity to ruthenium(II)-arene anticancer (RAPTA) compounds via click chemistry: The influence of hydrophobic chains. Journal of Organometallic Chemistry, 696(3), 772-779. [More Information]
Govender, P., Renfrew, A., Clavel, C., Dyson, P., Therrien, B., Smith, G. (2011). Antiproliferative activity of chelating N,O-and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds. Dalton Transactions, 40(5), 1158-1167. [More Information]
Mattsson, J., Zava, O., Renfrew, A., Sei, Y., Yamaguchi, K., Dyson, P., Therrien, B. (2010). Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage. Dalton Transactions, 39(35), 8248-8255. [More Information]
Egger, A., Hartinger, C., Renfrew, A., Dyson, P. (2010). Metabolization of [Ru(eta(^6)-C(6)H(5)CF(3)(pta)Cl(2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand. Journal of Biological Inorganic Chemistry, 15(6), 919-927. [More Information]
Schulz, J., Renfrew, A., Cisarova, I., Dyson, P., Stepnicka, P. (2010). Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene phosphanyl-carboxamide. Applied Organometallic Chemistry, 24(5), 392-397. [More Information]
Suss-Fink, G., Khan, F., Juillerat-Jeanneret, L., Dyson, P., Renfrew, A. (2010). Synthesis and anticancer activity of long-chain isonicotinic ester ligand-containing arene ruthenium complexes and naoparticles. Journal of Cluster Science: including nanoclusters and nanoparticles, 21(3), 313-324. [More Information]
Renfrew, A., Egger, A., Scopelliti, R., Hartinger, C., Dyson, P. (2010). Synthesis and characterisation of the water soluble bis-phosphine complex [Ru(eta(6)-cymene)(PPh(2)(o-C(6)H(4)O)-kappa(^2)-P,O)(pta)](^+) and an investigation of its cytotoxic effects (Invited publication). Academie des Sciences. Comptes Rendus. Chimie, 13(8-9), 1144-1150. [More Information]
Renfrew, A., Scopelliti, R., Dyson, P. (2010). Use of perfluorinated phosphines to provide thermomorphic anticancer complexes for heat-based tumor targeting. Inorganic Chemistry, 49(5), 2239-2246. [More Information]
Govender, P., Antonels, N., Mattsson, J., Renfrew, A., Dyson, P., Moss, J., Therrien, B., Smith, G. (2009). Anticancer activity of multinuclear arene ruthenium complexes coordinated to dendritic polypyridyl scaffolds. Journal of Organometallic Chemistry, 694(21), 3470-3476. [More Information]
Auzias, M., Gueniat, J., Therrien, B., Suss-Fink, G., Renfrew, A., Dyson, P. (2009). Arene-ruthenium complexes with ferrocene-derived ligands: Synthesis and characterization of complexes of the type [Ru(η6-arene)(NC5H4CH2NHOC-C5H4FeC5H5)Cl2] and [Ru(η6-arene)(NC3H3N(CH2)2O2C-C5H4FeC5H5)Cl2]. Journal of Organometallic Chemistry, 694(6), 855-861. [More Information]
Renfrew, A., Phillips, A., Egger, A., Hartinger, C., Bosquain, S., Nazarov, A., Keppler, B., Gonsalvi, L., Peruzzini, M., Dyson, P. (2009). Influence of Structural Variation on the Anticancer Activity of RAPTA-Type Complexes: ptn versus pta. Organometallics, 28(4), 1165-1172. [More Information]
Renfrew, A. (2009). Ruthenium(II) arene compounds as versatile anticancer agents. Chimia, 63(4), 217-219. [More Information]
Hartl, F., Renfrew, A., Lafolet, F., Mahabiersing, T., Calhorda, M., Chardon-Noblat, S., Haukka, M., Deronzier, A. (2009). Soluble redox-active polymetallic chains [{Ruo(CO)(L)(bpy)}m]n (bpy = 2,2'-bipyridine, L = PrCN, CI-; m = O, -1): Electrosynthesis and characterization. Inorganic Chemistry, 48(17), 8233-8244. [More Information]
Mattsson, J., Govindaswamy, P., Renfrew, A., Dyson, P., Stepnicka, P., Suss-Fink, G., Therrien, B. (2009). Synthesis, molecular structure, and anticancer activity of cationic arene ruthenium metallarectangles. Organometallics, 28(15), 4350-4357. [More Information]